Answers are grounded in this paper and cite their sources.
This case-control study evaluates the delay in treating relapsed or refractory diffuse large B-cell lymphoma due to distant access to chimeric antigen receptor T-cell (CAR T) therapy.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: